Cytokinetics (CYTK) EPS (Basic): 2009-2025
Historic EPS (Basic) for Cytokinetics (CYTK) over the last 16 years, with Sep 2025 value amounting to -$2.55.
- Cytokinetics' EPS (Basic) fell 87.50% to -$2.55 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.29, marking a year-over-year decrease of 16.91%. This contributed to the annual value of -$5.26 for FY2024, which is 3.49% up from last year.
- As of Q3 2025, Cytokinetics' EPS (Basic) stood at -$2.55, which was down 127.68% from -$1.12 recorded in Q2 2025.
- Cytokinetics' EPS (Basic)'s 5-year high stood at -$0.23 during Q2 2022, with a 5-year trough of -$2.55 in Q3 2025.
- Over the past 3 years, Cytokinetics' median EPS (Basic) value was -$1.35 (recorded in 2023), while the average stood at -$1.43.
- As far as peak fluctuations go, Cytokinetics' EPS (Basic) crashed by 1,800.00% in 2021, and later spiked by 73.26% in 2022.
- Cytokinetics' EPS (Basic) (Quarterly) stood at -$0.32 in 2021, then tumbled by 362.50% to -$1.48 in 2022, then grew by 6.76% to -$1.38 in 2023, then grew by 8.70% to -$1.26 in 2024, then plummeted by 87.50% to -$2.55 in 2025.
- Its EPS (Basic) was -$2.55 in Q3 2025, compared to -$1.12 in Q2 2025 and -$1.36 in Q1 2025.